Patterns and prognostic significance of cutaneous immune-related adverse events in non-small cell lung cancer

被引：4
|
作者：
Thompson, Leah L. [1 ,2 ]
Nadelmann, Emily R. [1 ,2 ]
Blum, Amy E. [1 ,2 ]
Yoon, Jaewon [1 ,2 ]
Polyakov, Nicole J. [1 ,2 ]
Kagan, Ruth D. [1 ,2 ]
Gainor, Justin F. [3 ]
Mooradian, Meghan J. [3 ]
Chen, Steven T. [1 ,2 ]
机构：
[1] Massachusetts Gen Hosp, Dept Dermatol, 50 Staniford St, Boston, MA 02114 USA
[2] Harvard Med Sch, 50 Staniford St, Boston, MA 02114 USA
[3] Massachusetts Gen Hosp, Dept Med, Div Hematol & Oncol, Ctr Canc, Boston, MA 02114 USA
来源：
EUROPEAN JOURNAL OF CANCER | 2021年 / 147卷
关键词：
ASSOCIATION;
D O I：
10.1016/j.ejca.2021.01.022
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：13 / 16
页数：4
相关论文
共 50 条
  • [1] Management of Immune-Related Adverse Events in Patients With Non-Small Cell Lung Cancer
    Burke, Michael
    Rashdan, Sawsan
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [2] PREDICTIVE BIOMARKERS OF SEVERE IMMUNE-RELATED ADVERSE EVENTS IN NON-SMALL CELL LUNG CANCER
    Magalhaes Ferreira, P.
    Serino, M.
    Freitas, C.
    Martins, M.
    Cardoso, C.
    Sousa, C.
    Santos, V.
    Araujo, D.
    Bastos, H.
    Magalhaes, A.
    Queiroga, H.
    Fernandes, G.
    Hespanhol, V.
    CHEST, 2022, 161 (06) : 311A - 311A
  • [3] Association of Immune-Related Adverse Events With Nivolumab Efficacy in Non-Small Cell Lung Cancer
    Haratani, Koji
    Hayashi, Hidetoshi
    Chiba, Yasutaka
    Kudo, Keita
    Yonesaka, Kimio
    Kato, Ryoji
    Kaneda, Hiroyasu
    Hasegawa, Yoshikazu
    Tanaka, Kaoru
    Takeda, Masayuki
    Nakagawa, Kazuhiko
    JAMA ONCOLOGY, 2018, 4 (03) : 374 - 378
  • [4] Frequency and clinical significance of immune-related adverse events in non-small-cell lung cancer
    Daniello, L.
    Bozorgmehr, F.
    Kuon, J.
    Gaissmaier, L.
    Kirchner, M.
    Elshiaty, M.
    Diekmann, L.
    Schneider, M.
    Liersch, S.
    Heussel, C. P.
    Winter, H.
    Herth, F.
    Elshafie, R.
    Muley, T.
    Senghas, K.
    Meister, M.
    Kriegsmann, K.
    Benesova, K.
    Kriegsmann, M.
    Bischoff, H.
    Stenzinger, A.
    Thomas, M.
    Christopoulos, P.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 147 - 147
  • [5] Immune-related adverse events in non-small cell lung cancer: Occurrence, mechanisms and therapeutic strategies
    Lin, Xuwen
    Xie, Mei
    Yao, Jie
    Ma, Xidong
    Qin, Lin
    Zhang, Xu-Mei
    Song, Jialin
    Bao, Xinyu
    Zhang, Xin
    Zhang, Yinguang
    Liu, Yiming
    Han, Wenya
    Liang, Yiran
    Jing, Ying
    Xue, Xinying
    CLINICAL AND TRANSLATIONAL MEDICINE, 2024, 14 (03):
  • [6] Therapeutic and Prognostic Implications of Immune-Related Adverse Events in Advanced Non-Small-Cell Lung Cancer
    Daniello, Lea
    Elshiaty, Mariam
    Bozorgmehr, Farastuk
    Kuon, Jonas
    Kazdal, Daniel
    Schindler, Hannah
    Shah, Rajiv
    Volckmar, Anna-Lena
    Lusky, Fabienne
    Diekmann, Leonore
    Liersch, Stephan
    Faehling, Martin
    Muley, Thomas
    Kriegsmann, Mark
    Benesova, Karolina
    Stenzinger, Albrecht
    Thomas, Michael
    Christopoulos, Petros
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] Multisystem Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors for Treatment of Non-Small Cell Lung Cancer
    Shankar, Bairavi
    Zhang, Jiajia
    Naqash, Abdul Rafeh
    Forde, Patrick M.
    Feliciano, Josephine L.
    Marrone, Kristen A.
    Ettinger, David S.
    Hann, Christine L.
    Brahmer, Julie R.
    Ricciuti, Biagio
    Owen, Dwight
    Toi, Yukihiro
    Walker, Paul
    Otterson, Gregory A.
    Patel, Sandip H.
    Sugawara, Shunichi
    Naidoo, Jarushka
    JAMA ONCOLOGY, 2020, 6 (12) : 1952 - 1956
  • [8] The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer
    Philip Bredin
    Jarushka Naidoo
    Cancer and Metastasis Reviews, 2022, 41 : 347 - 366
  • [9] The gut microbiome, immune check point inhibition and immune-related adverse events in non-small cell lung cancer
    Bredin, Philip
    Naidoo, Jarushka
    CANCER AND METASTASIS REVIEWS, 2022, 41 (02) : 347 - 366
  • [10] Correlation between immune-related adverse events and efficacy in non-small cell lung cancer treated with nivolumab
    Sato, Koichi
    Akamatsu, Hiroaki
    Murakami, Eriko
    Hayata, Atsushi
    Tokudome, Nahomi
    Akamatsu, Keiichiro
    Koh, Yasuhiro
    Ueda, Hiroki
    Nakanishi, Masanori
    Yamamoto, Nobuyuki
    ANNALS OF ONCOLOGY, 2017, 28 : 86 - 86
12345